JPH08509965A - 治療剤および治療方法 - Google Patents

治療剤および治療方法

Info

Publication number
JPH08509965A
JPH08509965A JP6520414A JP52041494A JPH08509965A JP H08509965 A JPH08509965 A JP H08509965A JP 6520414 A JP6520414 A JP 6520414A JP 52041494 A JP52041494 A JP 52041494A JP H08509965 A JPH08509965 A JP H08509965A
Authority
JP
Japan
Prior art keywords
antibody
animal
composition
gastrointestinal
proteolytic enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6520414A
Other languages
English (en)
Japanese (ja)
Inventor
チャンドラー、デイビッド・スペンサー
リード、ベンジャミン・ジョン
Original Assignee
ファーマ・パシフィック・ピーティーワイ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーマ・パシフィック・ピーティーワイ・リミテッド filed Critical ファーマ・パシフィック・ピーティーワイ・リミテッド
Publication of JPH08509965A publication Critical patent/JPH08509965A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP6520414A 1993-03-15 1994-03-15 治療剤および治療方法 Pending JPH08509965A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU7821 1989-12-11
AUPL782193 1993-03-15
PCT/AU1994/000121 WO1994021284A1 (fr) 1993-03-15 1994-03-15 Formulation et methode therapeutiques

Publications (1)

Publication Number Publication Date
JPH08509965A true JPH08509965A (ja) 1996-10-22

Family

ID=3776777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6520414A Pending JPH08509965A (ja) 1993-03-15 1994-03-15 治療剤および治療方法

Country Status (3)

Country Link
EP (1) EP0706400A1 (fr)
JP (1) JPH08509965A (fr)
WO (1) WO1994021284A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69432309D1 (de) * 1993-09-20 2003-04-24 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
AU2295497A (en) * 1996-04-03 1997-10-29 Elias Hakalehto Therapeutic and preventive method against harmful microbes
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
WO1998043610A1 (fr) * 1997-04-03 1998-10-08 Elias Hakalehto Procede de production de produits sucres contenant de la gelee
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
CZ15898A3 (cs) * 1998-01-19 1999-11-17 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid telat
CZ287989B6 (cs) * 1998-03-20 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid prasat
EP1100950A4 (fr) * 1998-07-30 2002-10-16 Wisconsin Alumni Res Found Usines d'anticorps bacteriens gastro-intestinaux
EP1446023B1 (fr) * 2001-11-12 2009-02-25 Mars, Incorporated Aliments pour chats et chiens
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
US20070280949A1 (en) * 2003-07-10 2007-12-06 Michelle Alfa Combination Therapy for Gastroenteric Diseases Caused by Microorganisms
WO2005016383A1 (fr) * 2003-08-14 2005-02-24 Merial Limited Compositions et vaccins contenant un(des) antigene(s) de cryptosporidium parvum et d'un autre pathogene
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
EP2261323A1 (fr) 2005-05-31 2010-12-15 The Iams Company Lactobacilles probiotiques félins
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
PL2480255T3 (pl) * 2009-09-23 2018-07-31 Thomas Julius Borody Terapia przewlekłych zakażeń jelitowych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
JPH0677017B2 (ja) * 1988-02-19 1994-09-28 富士薬品工業株式会社 ヒト▲ｉｖ▼型コラーゲンのサンドイツチ酵素免疫学的定量法
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis

Also Published As

Publication number Publication date
WO1994021284A1 (fr) 1994-09-29
EP0706400A1 (fr) 1996-04-17

Similar Documents

Publication Publication Date Title
JPH08509965A (ja) 治療剤および治療方法
WO1997020577A1 (fr) Formulation therapeutique amelioree et procede correspondant
Kuroki et al. Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk
Kovacs-Nolan et al. Avian egg antibodies: basic and potential applications
Tsubokura et al. Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens
UA115524C2 (uk) Композиції та способи лікування у клінічних застосуваннях широкого спектра дії, недиференційованих або змішаних
Quigley Iii et al. Effects of oral antibiotics or bovine plasma on survival, health and growth in dairy calves challenged with Escherichia coli
US20260021179A1 (en) Composition and Methods for Treating Acute Diarrhea and Enteric Infections in Animals
US20250222101A1 (en) Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine
US20020009429A1 (en) Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
NL2004099C2 (en) Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof.
Porter et al. Significance of immune mechanisms in relation to enteric infections of the gastrointestinal tract in animals
JPH11512746A (ja) 乳漿中の免疫グロブリンの単離方法
US20070264264A1 (en) Method and composition for conferring immunity in mammals
CA2235457A1 (fr) Prevention et traitement de l'infection a e. coli enterohemorrhagique
IE44814B1 (en) Agent for the prophylaxis and therapy of gastroenteritis
AU673589B2 (en) Therapeutic formulation and method
US6939954B2 (en) Isolated bovine lgG heavy chain protein and its use as an antimicrobial
KR101411995B1 (ko) 돼지 소모성 질병의 치료 또는 예방을 위한 젖소 초유 항체 조성물
US7244427B2 (en) Isolated bovine IgG heavy chain protein and its use as an antimicrobial
Ali Studies on the prevention of neonatal calf diarrhoea
HK1020682B (zh) 治療胃腸道損傷的方法